ING Evergreen Health Sciences S
ING Investors Trust 7337 E. Doubletree Ranch Road Scottsdale AZ 85258
Map
Phone: 800-366-0066
| Category: | Health | | Fund Family: | ING Retirement Funds | | Net Assets: | 196.16M | | Year-to-Date Return: | 15.75% | | Yield: | 0.00% | | Morningstar Rating: |  | | Fund Inception Date: | 03-May-04 |
|
Robert C. Junkin
Lead Manager since
31-Mar-07 | | | Junkin is managing director and senior portfolio manager with Evergreen?s Equity Management group. He has been with Evergreen since 2007. Previously, he served as a vice president and portfolio manager with MFC Global Investment Management where he was responsible for the John Hancock Health Sciences Fund (2005 to 2007) and as a co-manager for the Large Cap Equity Portfolio (2003-2007). |
| Min Initial Investment: | $0 | | Min Initial Investment, IRA: | NaN | | Min Initial Investment, AIP: | NaN | | Min Subsequent Investment: | NaN | | Min Subsequent Investment, IRA: | N/A | | Min Subsequent Investment, AIP: | N/A |
|
| |
| The investment seeks long-term capital growth. The portfolio normally invests at least 80% of assets in equity securities of healthcare companies, including, but not limited to, pharmaceutical companies, biotechnology companies, medical device and supply companies, managed care companies, and healthcare information and service providers. It may invest in domestic and foreign issued securities of relatively well-known and small, medium, and large sized companies. The fund is nondiversified. |
| Last Dividend
(15-Jul-08):
| 0.02 | | Last Cap Gain
(15-Jul-08):
| 0.62 | | Annual Holdings Turnover
| 56.00% | | Average for Category:
| 134.89% |
|
| Expense | IEHSX | Category
Avg | | Total Expense Ratio: | %
| 1.91% | | Max 12b1 Fee: | %
| N/A | | Max Front End Sales Load: | %
| 5.35% | | Max Deferred Sales Load: | %
| 2.88% | | 3 Yr Expense Projection*: |
$ YFT_NOT_APPLICABLE_ABBREVIATION | $719 | | 5 Yr Expense Projection*: |
$ YFT_NOT_APPLICABLE_ABBREVIATION | $1,076 | | 10 Yr Expense Projection*: |
$ YFT_NOT_APPLICABLE_ABBREVIATION | $2,105 |
|
|
0.67% Nasdaq 0.00%
Profile
